Clinical Trial Update: Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19 [NA]

View source ↗

Summary

A clinical trial is evaluating novel blood RNA biomarkers as a diagnostic tool to identify Long COVID (post-acute sequelae of SARS-CoV-2 infection).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: MaxWell Clinic, PLC | Conditions: Long COVID | NA | Status: RECRUITING